Articles & Video
COVID-19: Advice from the legal experts
We asked legal experts for their best tips and advice for pharmaceutical organisations during the COVID-19 pandemic.
COVID-19 Report: The Response to and Impacts on the Global Life Sciences Industry
COVID-19 Report: How is the life sciences industry developing a vaccine, treatment and testing for COVID-19 and what impact is it having on supply chain?
Interview- Roche’s approach to drug discovery, innovation and meeting patients' needs
James Sabry, Global Head of Roche Pharma Partnering, discusses Roche’s approach to discovering scientific breakthroughs, accelerating innovative research, collaborating with stakeholders, and meeting unmet medical needs in China and around the world.
Brazil & LATAM Pharmaceutical Regulations: Global Harmonisation & the Impact of Covid-19
We speak to two industry experts about how Brazil and LATAM region is working toward global regulatory harmonisation.
Global Pharmaceutical Regulatory Affairs Digital Week offers live practical advice
From future RIM to implementing IDMP, we take a first look at the insightful sessions of the new webinar series coming 24 June.
The Future of the Global Pharmaceutical Regulatory Affairs Industry
In a new interactive ebook, we take a deep dive into the challenges and trends we may see in pharmaceutical regulatory affairs over the next decade.
Pharma and Medical Device Regulations Content Library: Whitepapers and Reports Collection
Explore our collection of exclusive whitepapers and reports covering the hottest topics in pharma, biotech and medical device regulatory affairs and law with one simple registration.
Life Sciences in 2030 Survey: Complete to win a 2-day conference pass
We are a conducting a huge survey of life sciences professionals around the world on how the industry will look by 2030. Complete it here to get early access to the final report.
Building a global regulatory strategy
This whitepaper identifies the key factors, requirements and challenges affecting applying for marketing authorisation in different world regions.
China's changing pharmaceutical regulatory approval landscape
China has recently taken unprecedented steps to improve its healthcare and regulatory system. This whitepaper examines the recent changes and what opportunities and challenges they bring.